You are currently viewing the summary.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Summary
Antibiotics are an indispensable part of modern medicine. Yet, since the first β-lactam, aminoglycoside, macrolide, tetracycline, and fluoroquinolone classes of antibiotics were discovered and approved from 1940 to 1980, few antibiotics with novel mechanisms of action have been developed (1). At the same time, antibiotic resistance has been on the rise (see photo). Ensuring appropriate use, or stewardship, of antibiotics is critical to ensure that antibiotics retain their effectiveness against pathogens. In addition, the need for new classes of antibiotics has seen increasing international attention. To inform ongoing policy debates, we characterize trends in antibiotic research and development (R&D) over the past two decades.